Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson’s disease
Karsten Mueller(Max Planck Institute for Human Cognitive and Brain Sciences), Robert Jech(Charles University), Tommaso Ballarini(The University of Texas at San Antonio Health Science Center), Dušan Urgošík(Na Homolce Hospital), Štefan Holiga(Roche (Switzerland)), Evžen Růžička(Charles University), Harald E. Möller(Max Planck Institute for Human Cognitive and Brain Sciences), Filip Růžička(Charles University), Jan Roth(Charles University), Josef Vymazal(Na Homolce Hospital), Matthias L. Schroeter(Max Planck Institute for Human Cognitive and Brain Sciences)
Cited by 26
Related Papers
<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease
|European Journal of Neurology|2012|490
MRI of the lungs using hyperpolarized noble gases
|Magnetic Resonance in Medicine|2002|396
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
|Neurology|2005|273
Trial of Deferiprone in Parkinson’s Disease
|New England Journal of Medicine|2022|226
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology
|Trends in Neurosciences|2019|225